BRITTANY SOWDER: Open Payments
NPI 1043938822 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,647 in 81 payments from 15 companies in 2025. Trend: 2023 $1,315 · 2024 $1,017 · 2025 $1,647
Food & beverage: $1,647
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 13 | $291 |
| Vanda Pharmaceuticals Inc. | 7 | $231 |
| Alkermes, Inc. | 10 | $179 |
| ABBVIE INC. | 10 | $135 |
| Axsome Therapeutics, Inc. | 8 | $125 |
| E.R. Squibb & Sons, L.L.C. | 5 | $107 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $106 |
| Supernus Pharmaceuticals, Inc. | 4 | $103 |
| Teva Pharmaceuticals USA, Inc. | 4 | $90 |
| Corium, LLC | 4 | $72 |
Products named: INGREZZA, FANAPT, ARISTADA, VRAYLAR, COBENFY, CAPLYTA, Qelbree, REXULTI.
Industry payments across TN — which companies pay providers there.
